John M. Burkart

2.9k total citations
83 papers, 2.0k citations indexed

About

John M. Burkart is a scholar working on Nephrology, Emergency Medical Services and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John M. Burkart has authored 83 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Nephrology, 29 papers in Emergency Medical Services and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John M. Burkart's work include Dialysis and Renal Disease Management (60 papers), Central Venous Catheters and Hemodialysis (29 papers) and Health Systems, Economic Evaluations, Quality of Life (12 papers). John M. Burkart is often cited by papers focused on Dialysis and Renal Disease Management (60 papers), Central Venous Catheters and Hemodialysis (29 papers) and Health Systems, Economic Evaluations, Quality of Life (12 papers). John M. Burkart collaborates with scholars based in United States, Canada and Norway. John M. Burkart's co-authors include Michael V. Rocco, Anthony J. Bleyer, Jean R. Jordan, Barry I. Freedman, Gregory B. Russell, George L. Bakris, Eric D. Weinhandl, George W. Plonk, Peter A. McCullough and Richard H. Dean and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and American Journal of Kidney Diseases.

In The Last Decade

John M. Burkart

83 papers receiving 1.9k citations

Peers

John M. Burkart
José A. Díaz-Buxó United States
Graham Woodrow United Kingdom
Martin Wilkie United Kingdom
Wendy E. Bloembergen United States
John Moran United States
Alice Martin United States
Man-Ching Law Hong Kong
José A. Díaz-Buxó United States
John M. Burkart
Citations per year, relative to John M. Burkart John M. Burkart (= 1×) peers José A. Díaz-Buxó

Countries citing papers authored by John M. Burkart

Since Specialization
Citations

This map shows the geographic impact of John M. Burkart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Burkart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Burkart more than expected).

Fields of papers citing papers by John M. Burkart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Burkart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Burkart. The network helps show where John M. Burkart may publish in the future.

Co-authorship network of co-authors of John M. Burkart

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Burkart. A scholar is included among the top collaborators of John M. Burkart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Burkart. John M. Burkart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Plantinga, Laura, Tahsin Masud, Janice P. Lea, et al.. (2018). Post-hospitalization dialysis facility processes of care and hospital readmissions among hemodialysis patients: a retrospective cohort study. BMC Nephrology. 19(1). 186–186. 15 indexed citations
2.
Murea, Mariana, Gregory B. Russell, Pirouz Daeihagh, et al.. (2017). Efficacy and safety of low‐dose heparin in hemodialysis. Hemodialysis International. 22(1). 74–81. 12 indexed citations
3.
Pirkle, James L., Mary E. Comeau, Carl D. Langefeld, et al.. (2017). Effects of weight‐based ultrafiltration rate limits on intradialytic hypotension in hemodialysis. Hemodialysis International. 22(2). 270–278. 19 indexed citations
4.
Murea, Mariana, W. Mark Brown, Jasmin Divers, et al.. (2017). Vascular Access Placement Order and Outcomes in Hemodialysis Patients: A Longitudinal Study. American Journal of Nephrology. 46(4). 268–275. 11 indexed citations
5.
Bakris, George L., John M. Burkart, Eric D. Weinhandl, Peter A. McCullough, & Michael A. Kraus. (2016). Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use. American Journal of Kidney Diseases. 68(5). S15–S23. 28 indexed citations
6.
Kraus, Michael A., Sheru Kansal, Michael A. Copland, et al.. (2016). Intensive Hemodialysis and Potential Risks With Increasing Treatment. American Journal of Kidney Diseases. 68(5). S51–S58. 25 indexed citations
7.
Ma, Lijun, Carl D. Langefeld, Mary E. Comeau, et al.. (2016). APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease. Kidney International. 90(2). 389–395. 23 indexed citations
8.
Farney, Alan C., et al.. (2013). Treatment options for renal cell carcinoma in renal allografts: a case series from a single institution. Clinical Transplantation. 27(2). E199–205. 24 indexed citations
9.
Brunelli, Steven M., Keri L. Monda, John M. Burkart, et al.. (2013). Early Trends From the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS). American Journal of Kidney Diseases. 61(6). 947–956. 34 indexed citations
10.
Vachharajani, Tushar J., Shahriar Moossavi, Jean R. Jordan, et al.. (2011). Re-evaluating the Fistula First Initiative in Octogenarians on Hemodialysis. Clinical Journal of the American Society of Nephrology. 6(7). 1663–1667. 64 indexed citations
11.
Burkart, John M.. (2003). The ADEMEX Study and PD Adequacy. Blood Purification. 21(1). 37–41. 13 indexed citations
12.
Korbet, Stephen M., Joanne M. Bargman, John M. Burkart, et al.. (2000). A multicenter study of noncompliance with continuous ambulatory peritoneal dialysis exchanges in US and Canadian patients. American Journal of Kidney Diseases. 35(3). 506–514. 30 indexed citations
13.
Bleyer, Anthony J., John M. Burkart, Gregory B. Russell, & Patricia L. Adams. (1999). Dialysis Modality and Delayed Graft Function after Cadaveric Renal Transplantation. Journal of the American Society of Nephrology. 10(1). 154–159. 81 indexed citations
14.
Sevick, Mary Ann, Grethe S. Tell, Sally A. Shumaker, et al.. (1998). The Kidney Outcomes Prediction and Evaluation (KOPE) Study: A Prospective Cohort Investigation of Patients Undergoing Hemodialysis. Annals of Epidemiology. 8(3). 192–200. 6 indexed citations
15.
Burkart, John M.. (1996). Significance, Epidemiology, and Prevention of Peritoneal Dialysis Catheter Infections. Peritoneal Dialysis International. 16(2_suppl). 340–347. 11 indexed citations
16.
Burkart, John M., Martin A. Schreiber, Stephen M. Korbet, et al.. (1996). Solute Clearance Approach to Adequacy of Peritoneal Dialysis. Peritoneal Dialysis International. 16(5). 457–470. 27 indexed citations
17.
Bleyer, Anthony J., Grethe S. Tell, Gregory W. Evans, Walter H. Ettinger, & John M. Burkart. (1996). Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences. American Journal of Kidney Diseases. 28(1). 72–81. 65 indexed citations
18.
Burkart, John M.. (1995). Adequacy of Peritoneal Dialysis-Where Are We Going?. Blood Purification. 13(3-4). 180–198. 5 indexed citations
19.
Schreiber, Martin J., et al.. (1992). A 55-year-old man with hematuria and blood-tinged dialysate.. PubMed. 12(1). 61–71. 4 indexed citations
20.
Freedman, Barry I., John M. Burkart, & Samy S. Iskandar. (1990). Chronic Mesangiolytic Glomerulopathy in a Patient With SC Hemoglobinopathy. American Journal of Kidney Diseases. 15(4). 361–363. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026